Case Series on the Clinical Performance of VA Clavicle and Clavicle Hook Plate 2.7 Systems
Launched by AO INNOVATION TRANSLATION CENTER · Jun 4, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the effectiveness and safety of a special type of surgical plate used to treat injuries to the clavicle (collarbone) and the acromioclavicular joint, which connects the collarbone to the shoulder. The researchers will study at least 76 patients who have had a clavicle fracture or dislocation and received surgery using either the Clavicle Plate or the Clavicle Hook Plate from the VA-LCP system. They aim to collect information about how well these plates work and any potential side effects for up to two years after the surgery.
To participate, patients need to be at least 18 years old and have a recent injury to one side of their clavicle that requires surgery within three weeks of the injury. They should also be able to attend follow-up visits after their surgery. However, patients with certain conditions, like stable fractures, infections, or severe health issues, will not be eligible. Those who join the study can expect regular check-ups to monitor their recovery and the performance of the surgical plates.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>= 18 years
- * Unilateral clavicel injury and primary surgical treatment within 21 days from injury with a DPS VA-LCP® Clavicle Plate according to manufacturer's instruction use:
- • VA-LCP® Clavicle Plates 2.7: Fixation of clavicle bone fragments
- • VA-LCP® Clavicle Hook Plates 2.7: Fixation of lateral clavicle fractures and dislocations of the acromioclavicular joint
- • VA-LCP Clavicle Button Hook Plates 2.7: Fixation of acromioclavicular joint dislocations
- • Expected ability to attend postoperative FU visits
- • Patient informed and consent obtained according to the IRB/EC defined and approved procedures
- Exclusion Criteria:
- • Stable clavicle fractures
- • Systemic infection or infection localized to the site of the proposed implantation
- • Concomitant nerve or vessel injury
- • Polytrauma (Injury Severity Score ≥ 16)
- • BMI ≥40
- • Uncontrolled severe systemic disease or terminal illness
- • Intraoperative decision to use other implant
About Ao Innovation Translation Center
The AO Innovation Translation Center (AO ITC) is a leading clinical trial sponsor dedicated to advancing orthopedic research and innovation. With a focus on translating cutting-edge scientific discoveries into clinical applications, AO ITC collaborates with healthcare professionals, researchers, and industry partners to facilitate the development of novel therapies and technologies. By leveraging its extensive network and expertise, AO ITC aims to enhance patient care and outcomes in the field of musculoskeletal health, ensuring that innovative solutions are efficiently brought to market and accessible to those in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Columbia, South Carolina, United States
Münster, , Germany
Freiburg, , Germany
Luzern, , Switzerland
London, , United Kingdom
London, , United Kingdom
Wien, , Austria
Winston Salem, North Carolina, United States
Cleveland, Ohio, United States
Patients applied
Trial Officials
Simon Lambert
Principal Investigator
University College London Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials